Precursor B- or T-lymphoblastic lymphoma presenting with cutaneous involvement: a series of 13 cases including 7 cases of cutaneous T-lymphoblastic lymphoma

J Am Acad Dermatol. 2014 Feb;70(2):318-25. doi: 10.1016/j.jaad.2013.10.020. Epub 2013 Dec 4.

Abstract

Background: Lymphoblastic lymphoma (LBL) is a rare neoplasm of precursor lymphocytes, and cutaneous involvement is present in less than 20% of cases.

Objective: We sought to describe the clinical and histopathological features of cutaneous LBL.

Methods: We retrospectively examined the clinical and histologic features of 13 patients with cutaneous LBL, 6 with B-LBL and 7 with T-LBL.

Results: Five of 6 patients with B-LBL had lesions in the head and neck area, whereas 4 of 7 patients with T-LBL developed skin lesions on sites other than the head and neck. Seven patients (1 case of B-LBL, and 6 of 7 cases of T-LBL) developed multiple skin lesions, and the T-LBL cases frequently developed multiple skin lesions in the head, neck, and throughout the torso. Complete remission was achieved in 9 patients (3 patients with T-LBL and all patients with B-LBL).

Limitations: This study used a retrospective design and included a small sample size.

Conclusion: This study compared the clinical features of T-LBL and B-LBL, in particular the affected sites and number of skin lesions. Cutaneous T-LBL is likely to be accompanied by disseminated disease and has a relatively poor prognosis compared with B-LBL.

Keywords: ALL; LBL; TdT; acute lymphoblastic leukemia; lymphoblast; lymphoblastic lymphoma; lymphoma; precursor B lymphocytes; precursor T lymphocytes; skin; terminal deoxynucleotidyl transferase.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Biopsy, Needle
  • Child
  • Child, Preschool
  • Disease-Free Survival
  • Female
  • Humans
  • Immunohistochemistry
  • Lymphoma, T-Cell, Cutaneous / drug therapy
  • Lymphoma, T-Cell, Cutaneous / mortality*
  • Lymphoma, T-Cell, Cutaneous / pathology*
  • Male
  • Neoplasm Invasiveness / pathology
  • Neoplasm Staging
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / mortality*
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / pathology*
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / mortality*
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / pathology*
  • Prognosis
  • Retrospective Studies
  • Risk Assessment
  • Sampling Studies
  • Survival Analysis
  • Treatment Outcome
  • Young Adult